A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer
Condition(s):Castration-resistant Prostate CancerLast Updated:February 1, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Castration-resistant Prostate CancerLast Updated:February 1, 2021Terminated
Condition(s):Progressive Metastatic Prostate CancerLast Updated:March 24, 2021Active, not recruiting
Condition(s):Castration-Resistant Prostatic CancerLast Updated:October 9, 2020Recruiting
Condition(s):Prostate Cancer Metastatic; Castration-resistant Prostate CancerLast Updated:February 9, 2021Recruiting
Condition(s):Metastatic Prostate CancerLast Updated:March 29, 2021Active, not recruiting
Condition(s):Metastatic Prostate CancerLast Updated:February 9, 2021Recruiting
Condition(s):Hormone-Sensitive Prostate CancerLast Updated:April 12, 2021Recruiting
Condition(s):Prostate Cancer MetastaticLast Updated:February 21, 2021Completed
Condition(s):Adenocarcinoma of the Prostate; Bone Metastases; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Soft Tissue Metastases; Stage IV Prostate CancerLast Updated:August 25, 2020Completed
Condition(s):Prostate Cancer; Advanced Renal Cell Carcinoma; Advanced Urothelial Carcinoma; Genitourinary CancerLast Updated:December 22, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.